Estimating costs associated with paediatric Respiratory Syncytial Virus infection managed in the hospital setting in England.

Conclusion: The proposed cost of hospitalisation in medically attended RSV can be used to inform future pharmacoeconomic evaluation of RSV immunisation programmes to determine cost-effective prices.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Butfield, R., Said, J. Tags: Ethics and economics Source Type: research